VY4 Stock Overview
Engages in the production, distribution, and sale of cannabis products in Canada. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
SNDL Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.90 |
52 Week High | US$2.70 |
52 Week Low | US$1.20 |
Beta | 3.2 |
11 Month Change | -6.40% |
3 Month Change | 4.97% |
1 Year Change | 40.69% |
33 Year Change | -66.78% |
5 Year Change | -91.26% |
Change since IPO | -97.28% |
Recent News & Updates
Recent updates
Shareholder Returns
VY4 | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 3.5% | 1.4% | 0.8% |
1Y | 40.7% | -18.4% | 9.1% |
Return vs Industry: VY4 exceeded the German Pharmaceuticals industry which returned -19.3% over the past year.
Return vs Market: VY4 exceeded the German Market which returned 8.5% over the past year.
Price Volatility
VY4 volatility | |
---|---|
VY4 Average Weekly Movement | 6.4% |
Pharmaceuticals Industry Average Movement | 6.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: VY4 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: VY4's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 2,516 | Zach George | www.sndlgroup.com |
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores.
SNDL Inc. Fundamentals Summary
VY4 fundamental statistics | |
---|---|
Market cap | €500.88m |
Earnings (TTM) | -€75.26m |
Revenue (TTM) | €620.97m |
0.8x
P/S Ratio-6.8x
P/E RatioIs VY4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VY4 income statement (TTM) | |
---|---|
Revenue | CA$911.22m |
Cost of Revenue | CA$682.35m |
Gross Profit | CA$228.87m |
Other Expenses | CA$339.31m |
Earnings | -CA$110.44m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.42 |
Gross Margin | 25.12% |
Net Profit Margin | -12.12% |
Debt/Equity Ratio | 0% |
How did VY4 perform over the long term?
See historical performance and comparison